Treace Medical Concepts, Inc. (TMCI) P/E Ratio

TREACE MEDICAL CONCEPTS, INC. PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

• TREACE MEDICAL CONCEPTS, INC. pe ratio for the quarter ending 2026-06-30 was -4.32, a change of 3.21 year-over-year.
• TREACE MEDICAL CONCEPTS, INC. pe ratio for the quarter ending 2026-03-31 was -1.42, a change of 8.49 year-over-year.
• TREACE MEDICAL CONCEPTS, INC. pe ratio for the quarter ending 2025-12-31 was -2.66, a change of 5.66 year-over-year.
• TREACE MEDICAL CONCEPTS, INC. pe ratio for the quarter ending 2025-09-30 was -8.46, a change of -2.59 year-over-year.
• TREACE MEDICAL CONCEPTS, INC. pe ratio for fiscal 2026 was -4.32.
• TREACE MEDICAL CONCEPTS, INC. pe ratio for fiscal 2025 was -2.66, a change of 5.66 from fiscal 2024.
• TREACE MEDICAL CONCEPTS, INC. pe ratio for fiscal 2024 was -8.31, a change of 7.58 from fiscal 2023.
• TREACE MEDICAL CONCEPTS, INC. pe ratio for fiscal 2023 was -15.9, a change of 13.97 from fiscal 2022.